Login / Signup
Pharmacogenomics for Clinical Trials of COVID-19 Medicines: Why Is This Important Now?
Semra Şardaş
Vural Özdemir
Published in:
Omics : a journal of integrative biology (2021)
Keyphrases
</>
clinical trial
coronavirus disease
sars cov
phase ii
clinical decision support
adverse drug
respiratory syndrome coronavirus
open label
double blind
randomized controlled trial
phase iii
emergency department